China Showcase Digital at Biotech Showcase

September 20-30, 2021
Live Event: September 20-23 in Boston, MA
Digital Event: September 28-30

TIDES USA is the flagship must-attend event in the TIDES: Oligonucleotide & Peptide Therapeutics portfolio. It is the world’s largest gathering for those interested in accelerating oligonucleotide, peptide, mRNA and genome editing products from early discovery to late-stage development and commercialization. 

The program features 4 concurrent tracks covering the following 6 scientific themes including in-depth development strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing. 


  1. Oligonucleotide CMC and Targeted Delivery
  2. Oligonucleotide Discovery to Clinic and CMC

3. Peptides
4. mRNA Therapeutics & Genome Editing


Fill out the Form Below


Katalin Karikó, Ph.D.
Senior Vice President, RNA Protein Replacement Therapy
BioNTech RNA Pharmaceuticals GmbH

John Maraganore, Ph.D.
Chief Executive Officer
Alnylam Pharmaceuticals

Holly Kordasiewicz, Ph.D.
Vice President Neurology 
Ionis Pharmaceuticals

My Long Road from the 2’-5’ Oligos to the 
mRNA Vaccine 

RNAi Therapeutics: Past, Present, and (Mostly) Future

Antisense Oligonucleotides for the Treatment of Neurological Diseases

Approved Commercial Peptide Vyleesi and A Family of Melanocortin Peptides in Late Stage Development  

Carl Spana
Chief Executive Officer
Palatin Technologies  

Discovery and Development of Rusfertide (PTG-300) Being Developed for Treatment of PV

David Liu, Ph.D.
Chief Scientific Officer, 
Head of Discovery & 
Pre-Clinical Development
Protagonist Therapeutics

Eli Lilly’s Progress in the Discovery and Development of Oligonucleotide Therapeutics: Strategy, Science, Pipeline

Andrew Adams, Ph.D.
Vice President, New Therapeutic Modalities
Eli Lilly & Company

Discovery of Nucleic Acid Binding Molecules and Machine Learning Enabled Delivery of Antisense Oligonucleotides

Bradley Pentelute, Ph.D.
Professor, Chemistry, Massachusetts Institute of Technology

How We’re Developing the Next Generation of mRNA Delivery LNPs

Kerry Benenato, Ph.D.
Vice President, Platform Chemistry and Formulation Discovery
Moderna Therapeutics


TIDES USA's In-person experience will be organized in accordance with Informa's AllSecure Health & Safety Standards as well as official government and local authority guidance. 

"TIDES USA is one of the best conferences to stay up-to-date on the research other companies are doing.  Most companies working in this area are well represented at the conference so it is a great opportunity for networking." 
- TIDES USA 2019 Live Event Attendee

"A big thank you to entire TIDES staff and participants on your fantastic work. You have a top-notch operation. I always prefer to meet people face to face rather behind the machine but after my participation at TIDES virtual, it changed my perception inside out. It was very much like meeting people in real time. 
- TIDES USA 2020 Virtual Attendee